[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100554904":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":26,"centralContacts":26,"locations":30,"responsibleParty":50,"collaborators":54,"id":57,"slug":58,"hasResults":59,"nctId":60,"briefTitle":61,"officialTitle":61,"acronym":26,"eligibilityCriteria":62,"healthyVolunteers":59,"sex":63,"minAge":64,"maxAge":65,"enrollmentInfo":66,"targetDuration":26,"studyType":69,"phases":70,"briefSummary":72,"conditions":73,"keywords":75,"overallStatus":80,"whyStopped":26,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":82,"startDateStruct":85,"completionDateStruct":87,"leadSponsor":89,"locationsCount":90},{"fullName":5,"class":6},"Baylor Research Institute","OTHER",[8,15],{"label":9,"type":10,"description":11,"interventionNames":12},"Group A","EXPERIMENTAL","Group A will prescribe study participants in group 1 acetaminophen and ibuprofen alternating treatment every three hours. The dosage will be weight-based.",[13,14],"Drug: Acetaminophen","Drug: Ibuprofen",{"label":16,"type":17,"description":18,"interventionNames":19},"Group B","ACTIVE_COMPARATOR","Group B will be prescribed acetaminophen and ibuprofen combined treatment every 6 hours. The dosage will be weight-based.",[13,14],[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DRUG","Acetaminophen","administered alternatively with other drug",[9,16],null,{"type":22,"name":28,"description":24,"armGroupLabels":29,"otherNames":26},"Ibuprofen",[9,16],[31],{"facility":32,"status":26,"city":33,"state":34,"zip":35,"country":36,"countryCode":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"Baylor Scott & White Health Temple Market","Temple","Texas","76508","United States","US",{"type":39,"coordinates":40},"Point",[41,42],-97.34278,31.09823,{"lat":42,"lon":41},[45],{"name":46,"role":47,"phone":48,"phoneExt":26,"email":49},"Marlene T Porter, PhD","CONTACT","254-724-9069","marlene.porter@bswhealth.org",{"type":51,"investigatorFullName":52,"investigatorTitle":53,"investigatorAffiliation":5,"oldNameTitle":26,"oldOrganization":26},"PRINCIPAL_INVESTIGATOR","Marlene Porter","Principal Investigator",[55],{"name":56,"class":6},"Baylor Scott and White Health","100554904","phase-4-comparing-the-difference-in-pain-control-in-the-pediatric-general-surgery-population-to-alternate-or-combine-acetaminophen-and-ibuprofen-100554904",false,"NCT06505148","Comparing the Difference in Pain Control in the Pediatric General Surgery Population: to Alternate or Combine Acetaminophen and Ibuprofen?","Inclusion Criteria:\n\n* Age group: 3 years to 18 years\n* General surgery service (hernia, appendectomy, chole, circumcision, wounds, vacs, implanted central line, etc.)\n\nExclusion Criteria:\n\n* Patients who are allergic to acetaminophen and\u002For ibuprofen\n* Patients being evaluated by SANE or evaluated for nonaccidental trauma\n* Patients admitted post-op\n\nThe study will take place at McLane Children's Hospital Temple Market. Patients who are pregnant.","ALL","3 Years","18 Years",{"count":67,"type":68},80,"ESTIMATED","INTERVENTIONAL",[71],"PHASE4","To examine the difference in pain control in the pediatric general surgery population alternating acetaminophen and Ibuprofen q 3 hours vs giving them simultaneous combination therapy around the clock.",[74],"Pediatric Disorder",[76,77,78,79],"non opioid","pain management","pediatric pain","pediatric pain management","NOT_YET_RECRUITING","2024-07-18",{"date":83,"type":84},"2024-07-22","ACTUAL",{"date":86,"type":68},"2024-08-01",{"date":88,"type":68},"2025-08-01",{"name":5,"class":6},1]